# The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease

> **NCT03577652** · NA · COMPLETED · sponsor: **Shenyang Northern Hospital** · enrollment: 108 (actual)

## Conditions studied

- Coronary Artery Disease
- Ticagrelor

## Interventions

- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT03577652
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-10
- **Primary completion:** 2018-01-10
- **Final completion:** 2018-01-10
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03577652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03577652, "The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03577652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*